Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy
Neoadjuvant systemic treatment elicits a pathologic complete response (pCR) in about 35% of women with breast cancer. In such cases, breast surgery may be considered overtreatment. We evaluated multivariate algorithms using patient, tumor, and vacuum-assisted biopsy (VAB) variables to identify patients with breast pCR.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Andr é Pfob, Chris Sidey-Gibbons, Han-Byoel Lee, Marios Konstantinos Tasoulis, Vivian Koelbel, Michael Golatta, Gaiane M. Rauch, Benjamin D. Smith, Vicente Valero, Wonshik Han, Fiona MacNeill, Walter Paul Weber, Geraldine Rauch, Henry M. Kuerer, Joerg He Tags: Original Research Source Type: research
More News: Breast Cancer | Breast Surgery | Cancer | Cancer & Oncology | Neoadjuvant Therapy | Women